[Clinical-chemical tests to judge the security of the Berotec pocketinhaler application (author's transl)].
D000328:Adult; D000336:Aerosols; D000410:Alanine Transaminase / Q000097:blood; D000469:Alkaline Phosphatase / Q000097:blood; D001798:Blood Proteins / Q000032:analysis; D056486:Chemical and Drug Induced Liver Injury; D003402:Creatine Kinase / Q000097:blood; D005260:Female; D006331:Heart Diseases / Q000139:chemically induced; D006801:Humans; D007527:Isoenzymes; D007770:L-Lactate Dehydrogenase / Q000097:blood; D008297:Male; D009921:Metaproterenol / Q000009:adverse effects*; D008875:Middle Aged; D010636:Phenols / Q000009:adverse effects; D013925:Thromboplastin
D000336:Aerosols; D001798:Blood Proteins; D007527:Isoenzymes; D010636:Phenols; D009921:Metaproterenol; D013925:Thromboplastin; D007770:L-Lactate Dehydrogenase; D000410:Alanine Transaminase; D003402:Creatine Kinase; D000469:Alkaline Phosphatase
Klinisch-chemische Untersuchungen zur Beurteilung der Sicherheit der Anwendung von Berotec-Dosier-Aerosol.